Life Sciences Leaders @ NLSDays

NLSDays 2022

Helena Strigård, SwedenBIO CEO, writing about a new Nordic Saga

Christina Östberg Lloyd, Pharmiva CEO, about NLSDays’ Gender Science super session

Masha Strømme, PAACS Invest Co-Chair, about NLSDays’ Gender Science super session

Per Falk, Ferring Pharmaceuticals President, about NLSDays’Gender Science super session

NLSDays 2021

Emmanuel Lignier, Cytiva CEO, shares his commitment to Nordic life sciences and entrepreneurs.

NLSDays – NLSInvest 2021: What are international investors are looking for? (Red Alpine & TVM Capital)

NLSInvest 2021: What’s in it for Nordic Life Science companies? (Mode Sensors, Sartar & Hemispherian)

NLSInvest – NLSDays: Why returning on a regular basis? (Gedea Biotech)

Gianfranco Grompone, BioGaia CSO about NLSDays’ Microbiome super session

Sarah Lidé, Senior Strategy Project Manager MVA about NLSDays’ Microbiome super session

NLSDays – NLSInvest 2021: What are international investors are looking for? (Graybella Capital,  IPF Partners & Illumina Ventures)

NLSInvest 2021: What’s in it for Nordic Life Science companies? (Ciana Therapeutics & Epiendo Pharmaceuticals)

NLSDays – NLSInvest 2021: What are international investors are looking for? (Asabys & Bootstrap)

NLSInvest 2021: What’s in it for Nordic Life Science companies? (2N Pharma)

Abdel Halim, President, Biomakers and Diagnostics Consulting about NLSDays’ Precision Medicine Super Session

Karin Conde-Knape, Senior Vice President, Global Drug Discovery, Novo Nordisk Consulting about NLSDays’ Precision Medicine Super Session

Sam Oddson, CMO & Co-founder, SidekickHealth about NLSDays’ The new cross-industry playground Super Session

Jessica Shull, Industry Relations, Digital Therapeutics Alliance about NLSDays’ The new cross-industry playground super session

NLSDays – NLSInvest 2021: What are international investors are looking for? (Abbvie, M Ventures)